about
The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironmentTumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesAutologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.MDSCs in cancer: Conceiving new prognostic and therapeutic targets.Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma.Tumor-Induced Myeloid-Derived Suppressor Cells.Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy.Overview of the optical properties of fluorescent nanoparticles for optical imaging.Anti-telomerase T cells adoptive transfer.Optical emission of 223 Radium: in vitro and in vivo preclinical applications.Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.Methods to Measure MDSC Immune Suppressive Activity In Vitro and In VivoInduction of immunosuppressive functions and NF-κB by FLIP in monocytesThe dark side of tumor-associated endothelial cellsHyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimensT-cell tracking using Cerenkov and radioluminescence imagingImmunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasoundImmunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic diseaseThe Endless Saga of Monocyte Diversity
P50
Q28396481-35A69ED1-1A15-4CF0-9129-11DC23681414Q34044797-2E6A8EF2-31D9-46D1-95BB-C9D3CFEA95D6Q36004284-85A0CD11-6690-474A-BB49-D6C7C6A153E4Q37679962-28B7C670-2BD9-4B59-9689-CD21433842FFQ38563094-A648B28C-B225-4059-B83B-78DB1C0E3679Q38565385-ECD84951-43AC-4CBA-85F7-483F66A168BEQ38769825-F2A4FC60-10F4-4021-8BCC-CDAABD10624CQ38834815-3F93C2A6-43D8-4F53-BBCF-9046C2EF38D6Q38874538-4DA87591-626A-491B-A4D1-327C114B9F98Q41068034-4B81043F-3250-4D58-9F46-2705C6FDAF4AQ42352610-E2F3DFC5-3829-4C9F-9780-396A575BE219Q47142915-B273A352-F83D-4420-B6F2-6FD4C41E84B7Q48152679-D0A538E9-D6B1-4035-8C5B-A160CE26851CQ49897464-320A607A-ACCD-4BF0-820A-F9C33EABFC46Q57283385-12585DF4-01CB-4511-A6CE-4910BB7B8191Q59792591-50885C22-CB46-40D5-B592-9FC52BD347BCQ87911779-4CAE11BA-CAC1-43F7-BF80-2B515D10701DQ88644572-E47BC2B7-ADAC-4F6E-A707-4BC391189D1EQ88707852-62124C68-1FF3-4D9C-BC11-61857840B3D6Q90166631-7C353FC9-E199-45FF-983A-3CEA4D9B4B2DQ90569349-88DF8FB8-FA64-47B7-A115-2947B573636CQ92797185-98A4CF5B-6420-4591-9B73-EB5B804812A7Q92857692-05C4F0E4-14D8-4BB3-A8B9-1441D72B711A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Francesco De Sanctis
@en
Francesco De Sanctis
@nl
type
label
Francesco De Sanctis
@en
Francesco De Sanctis
@nl
prefLabel
Francesco De Sanctis
@en
Francesco De Sanctis
@nl
P31
P496
0000-0002-7232-7585